Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

CGEMCGEM
Showing 8 of 22 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in CULLINAN THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 464,034 shares of CGEM (CULLINAN THERAPEUTICS INC), worth $8.5M as of 2026-Q2. The position was increased (+7.2% shares). CGEM represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$8.5M

Current Shares

464,034

Total Value Change

+$1.4M

Total Shares Change

+40,075

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
464,034
+7.2%
$8.5M0.0%$18.21
30
2026-Q1
Decreased
432,893
-0.8%
$6.2M0.0%$15.73
0
2025-Q4
Increased
436,273
+8.3%
$4.5M0.0%$9.92
29
2025-Q3
Decreased
402,638
-7.5%
$2.4M0.0%$5.97
0
2025-Q2
Increased
435,516
+2.6%
$3.3M0.0%$7.76
27
2025-Q1
Decreased
424,262
-1.6%
$3.2M0.0%$8.02
0
2024-Q4
Increased
430,971
+1.6%
$5.2M0.0%$12.20
27
2024-Q3
Increased
423,959
+14.4%
$7.1M0.0%$17.19
31

Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, STATE STREET CORP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used